149 related articles for article (PubMed ID: 16518276)
1. Hepatic metastases from carcinomas of unknown primary site.
Pouessel D; Thezenas S; Culine S; Becht C; Senesse P; Ychou M
Gastroenterol Clin Biol; 2005 Dec; 29(12):1224-32. PubMed ID: 16518276
[TBL] [Abstract][Full Text] [Related]
2. Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
Lazaridis G; Pentheroudakis G; Fountzilas G; Pavlidis N
Cancer Treat Rev; 2008 Dec; 34(8):693-700. PubMed ID: 18584969
[TBL] [Abstract][Full Text] [Related]
3. [Carcinoma of unknown primary site. Apropos of 100 patients treated at the Montpellier regional center of cancer prevention].
Culine S; Gazagne L; Ychou M; Romieu G; Fabbro M; Cupissol D; Dubois JB
Rev Med Interne; 1998 Oct; 19(10):713-9. PubMed ID: 9827443
[TBL] [Abstract][Full Text] [Related]
4. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
Shaw PH; Adams R; Jordan C; Crosby TD
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
[TBL] [Abstract][Full Text] [Related]
6. Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients.
Algin E; Ozet A; Gumusay O; Yilmaz G; Buyukberber S; Coskun U; Baykara M; Cetin B; Yıldız R; Benekli M
Wien Klin Wochenschr; 2016 Jan; 128(1-2):42-7. PubMed ID: 26373751
[TBL] [Abstract][Full Text] [Related]
7. Hepatic metastases from an unknown primary neoplasm (UPN): survival, prognostic indicators and value of extensive investigations.
Hogan BA; Thornton FJ; Brannigan M; Browne TJ; Pender S; O'Kelly P; Lyon SM; Lee MJ
Clin Radiol; 2002 Dec; 57(12):1073-7. PubMed ID: 12475531
[TBL] [Abstract][Full Text] [Related]
8. Hepatic neuroendocrine metastases: does intervention alter outcomes?
Chamberlain RS; Canes D; Brown KT; Saltz L; Jarnagin W; Fong Y; Blumgart LH
J Am Coll Surg; 2000 Apr; 190(4):432-45. PubMed ID: 10757381
[TBL] [Abstract][Full Text] [Related]
9. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.
Seve P; Ray-Coquard I; Trillet-Lenoir V; Sawyer M; Hanson J; Broussolle C; Negrier S; Dumontet C; Mackey JR
Cancer; 2006 Dec; 107(11):2698-705. PubMed ID: 17063500
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables.
Ponce Lorenzo J; Segura Huerta A; Díaz Beveridge R; Giménez Ortiz A; Aparisi Aparisi F; Fleitas Kanonnikoff T; Richart Aznar P; de la Cueva Sapiña H; Montalar Salcedo J
Clin Transl Oncol; 2007 Jul; 9(7):452-8. PubMed ID: 17652059
[TBL] [Abstract][Full Text] [Related]
11. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
[TBL] [Abstract][Full Text] [Related]
12. CUP Syndrome in Neuroendocrine Neoplasia: Analysis of Risk Factors and Impact of Surgical Intervention.
Begum N; Wellner U; Thorns C; Brabant G; Hoffmann M; Bürk CG; Lehnert H; Keck T
World J Surg; 2015 Jun; 39(6):1443-51. PubMed ID: 25665670
[TBL] [Abstract][Full Text] [Related]
13. [Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site].
Pejcić I; Vrbić S; Filipović S; Sćekić M; Petković I; Pejcić L; Djenić N
Vojnosanit Pregl; 2010 Sep; 67(9):723-31. PubMed ID: 20954411
[TBL] [Abstract][Full Text] [Related]
14. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
[TBL] [Abstract][Full Text] [Related]
15. Survival outcomes and prognostic factors of transcatheter arterial chemoembolization for hepatic neuroendocrine metastases.
Hur S; Chung JW; Kim HC; Oh DY; Lee SH; Bang YJ; Kim WH
J Vasc Interv Radiol; 2013 Jul; 24(7):947-56; quiz 957. PubMed ID: 23602421
[TBL] [Abstract][Full Text] [Related]
16. [Hepatic metastasis of unknown primary site].
Mousseau M; Schaerer R; Lutz JM; Ménégoz F; Faure H; Swiercz P
Bull Cancer; 1991; 78(8):725-36. PubMed ID: 1932839
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of unknown primary: retrospective study of 437 patients treated at Salah Azaiez Institute.
Fehri R; Rifi H; Alboueiri A; Malouche D; Ayadi M; Rais H; Mezlini A
Tunis Med; 2013 Mar; 91(3):205-8. PubMed ID: 23588636
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
19. Unknown primary tumors metastatic to liver.
Ayoub JP; Hess KR; Abbruzzese MC; Lenzi R; Raber MN; Abbruzzese JL
J Clin Oncol; 1998 Jun; 16(6):2105-12. PubMed ID: 9626210
[TBL] [Abstract][Full Text] [Related]
20. Unknown primary adenocarcinomas: a single-center experience.
Uzunoglu S; Erdogan B; Kodaz H; Cinkaya A; Turkmen E; Hacibekiroglu I; Sari A; Ozen A; Usta U; Cicin I
Bosn J Basic Med Sci; 2016 Nov; 16(4):292-297. PubMed ID: 27455119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
